Thrombolysis in submassive pulmonary embolism? Yes
Thrombolysis in submassive pulmonary embolism? No
The platelet P2Y receptors as targets for new antithrombotic drugs
Tweezing apart von Willebrand factor–glycoprotein Ib–IX adhesive signaling
Mechanism of action of recombinant factor VIIa
Do lipid rafts contribute to platelet activation?
Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist
Glycoprotein Ib–IX‐mediated activation of integrin αIIbβ3
How factor VIIa works in hemophilia
Concentration of rafts in platelet filopodia correlates with recruitment of c‐Src and CD63 to these domains
Megakaryocytes and beyond
Nitric oxide and its relationship to thrombotic disorders
Fresh frozen plasma reduces thrombin formation in newborn infants
Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion
Lipid metabolism and occurrence of post‐percutaneous transluminal coronary angioplasty restenosis
Effect of long‐term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX
ARP1 interacts with the 5′ flanking region of the coagulation factor VII gene
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A
Severe factor V deficiency
Novel Aα chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization
Two novel fibrinogen variants found in patients with pulmonary embolism and their families
Factor Xa is highly protected from antithrombin–fondaparinux and antithrombin–enoxaparin when incorporated into the prothrombinase complex
Endogenous plasmin converts Glu‐plasminogen to Lys‐plasminogen on the monocytoid cell surface
Plasmic degradation modulates activity of fibrinogen‐bound fibroblast growth factor‐2
Activation of GPVI by collagen is regulated by α2β1 and secondary mediators
Sulfatides inhibit platelet adhesion to von Willebrand factor in flowing blood
Platelet characteristics associated with coronary artery disease
FGF‐2 but not FGF‐1 binds fibrin and supports prolonged endothelial cell growth
Thrombophilia testing
Exercise‐induced activation of coagulation in thrombophilia
Prekallikrein (PK) Tokushima
Microthrombus formation enhances tumor necrosis factor‐α production in the development of ischemia/reperfusion‐induced liver injury in rats
Interpretation of platelet inhibition by clopidogrel and the effect of non‐responders
The early antiplatelet effects of clopidogrel loading for coronary stenting and the long‐term stability of inhibition
Anticoagulation patterns and clinical decision‐making following an intermediate ventilation‐perfusion scan in pulmonary thromboembolism
Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe hemophilia A in the Czech Republic
Venous thromboembolism in asymptomatic carriers of factor V Leiden mutation from symptomatic families
Spontaneous venous thrombosis in inflammatory bowel disease
Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism
Homocysteine plasma levels after suspension of vitamin treatment
Melvin Joel Silver